1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Hungary Pharmaceuticals and Healthcare Report Q3 2016

Hungary Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 82 pages

Includes 3 FREE quarterly updates

BMI View: Hungary's pharmaceuticals and healthcare market will remain a limited prospect forinvestment due to the systemic underfunding of the healthcare sector. While improvements to healthcareprovision and accessibility are likely to increase demand for medicines, the country's revenue earningopportunities remain modest in comparison to neighbouring markets.

Headline Expenditure Projections

- Pharmaceuticals: HUF660.8bn (USD2.4bn) in 2015 to HUF667.6bn (USD2.3bn) in 2016; +1.0% inlocal currency terms and -2.3% in US dollar terms. Forecast in local currency terms revised slightlydownwards from last quarter.

- Healthcare: HUF2.5trn (USD9.0bn) in 2015 to HUF2.6trn (USD9.1bn) in 2016; +5.0% in local currencyterms and 1.6% in US dollar terms. Forecast revised upwards from last quarter.

Table Of Contents

Hungary Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Hungary 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Hungary 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2012-2020) 17
Prescription Drug Market 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Hungary 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Hungary 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hungary 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Hungary 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Hungary 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Hungary 2014-2020) 30
Industry Risk Reward Index 31
Central And Eastern Europe Risk/Reward Index - Q3 2016 31
Hungary Risk/Reward Index 37
Rewards 37
Risks 37
Regulatory Review 39
Intellectual Property Issues 41
Pricing Regime 42
Table: OEP Reimbursement Changes, September 2014 44
Reimbursement Regime 44
Market Overview 47
Healthcare Sector 48
Table: Healthcare Resources (Hungary 2010-2015) 49
Table: Healthcare Personnel (Hungary 2010-2015) 50
Table: Healthcare Activity (Hungary 2010-2015) 50
Research and Development 51
Clinical Trials 52
Epidemiology 53
Competitive Landscape 56
Research-Based Industry 56
Table: Multinational Market Activity 58
Generic Drugmakers 59
Pharmaceutical Distribution 60
Pharmaceutical Retail Sector 61
Company Profile 63
Egis Pharmaceuticals (Servier) 63
Gedeon Richter 66
Demographic Forecast 71
Table: Population Headline Indicators (Hungary 1990-2025) 72
Table: Key Population Ratios (Hungary 1990-2025) 72
Table: Urban/Rural Population and Life Expectancy (Hungary 1990-2025) 73
Table: Population By Age Group (Hungary 1990-2025) 73
Table: Population By Age Group % (Hungary 1990-2025) 74
Glossary 76
Methodology 78
Pharmaceutical Expenditure Forecast Model 78
Healthcare Expenditure Forecast Model 78
Notes On Methodology 79
Risk/Reward Index Methodology 80
Index Overview 81
Table: Pharmaceutical Risk/Reward Index Indicators 81
Indicator Weightings 82

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.